Home › Research › Topics › scopolamine-induced
scopolamine-induced
3 studies tagged scopolamine-induced, dated 2005-10-01 to 2018-06-25. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Amelioration of Cognitive Deficit by Embelin in a Scopolamine-Induced Alzheimer's Disease-Like Condition in a Rat Model 2018-06-25
- Analogous β-Carboline Alkaloids Harmaline and Harmine Ameliorate Scopolamine-Induced Cognition Dysfunction by Attenuating Acetylcholinesterase Activity, Oxidative Stress, and Inflammation in Mice 2018-04-10
- Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor 2005-10-01
Studies
3 studies carry this tag.
Date range
2005 to 2018
Top journals
- Frontiers in pharmacology 2
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Embelin (2,5-dihydroxy-3-undecyl-1,4-benzoquinone) is one of the active components (2.3%) found in Embelia ribes Burm fruits.
-
The analogous β-carboline alkaloids, harmaline (HAL) and harmine (HAR), possess a variety of biological properties, including acetylcholinesterase (AChE) inhibitory activity, antioxidant, anti-inflammatory, and many others, and have great potential for treating Alzheimer's disease (AD).
-
Robust effects of single-dose donepezil on cognition can be readily observed, with the use of a complex hidden maze learning task, both with and without a scopolamine-induced deficit model in healthy elderly adults.